TokenPost·
Moderna Shares Gain 11.04% Ahead of Melanoma Trial Data
11.04%
share gain
The stock closed at $242.08 on Oct. 20, about 284.5% above its Aug. 18 close, as investors await detailed Phase 3 results.
More news
- TokenPostXRP Ledger Sees Intermittent Slow Closes as Operators Investigate
- TokenPostBitcoin Trading Address Adds About $1.6 Million to Long Position
- TokenPostFrench 10-Year Bond Yield Tops 5% for First Time Since 2002
- Crypto BriefingPerplexity’s JOLT method matches GRPO accuracy with 6.5x fewer training tokens
- TokenPostPendle Partners With Janus Henderson on $30 Billion CLO Strategy
- TokenPostDrift Exploit Wallet Deposits 24,885 ETH Into Tornado Cash